68.93
price down icon1.50%   -1.05
after-market Handel nachbörslich: 68.93
loading
Schlusskurs vom Vortag:
$69.98
Offen:
$68.44
24-Stunden-Volumen:
612.97K
Relative Volume:
0.57
Marktkapitalisierung:
$3.21B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-38.99M
KGV:
-23.00
EPS:
-2.9966
Netto-Cashflow:
$-24.94M
1W Leistung:
-1.53%
1M Leistung:
+40.36%
6M Leistung:
+28.24%
1J Leistung:
+83.81%
1-Tages-Spanne:
Value
$68.30
$71.15
1-Wochen-Bereich:
Value
$68.27
$71.15
52-Wochen-Spanne:
Value
$36.93
$74.00

Soleno Therapeutics Inc Stock (SLNO) Company Profile

Name
Firmenname
Soleno Therapeutics Inc
Name
Telefon
650-213-8444
Name
Adresse
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
Name
Mitarbeiter
92
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-05
Name
Neueste SEC-Einreichungen
Name
SLNO's Discussions on Twitter

Vergleichen Sie SLNO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
SLNO
Soleno Therapeutics Inc
68.93 3.21B 0 -38.99M -24.94M -2.9966
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.52 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.49 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
595.70 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.75 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
229.22 26.16B 3.81B -644.79M -669.77M -6.24

Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-05 Fortgesetzt Stifel Buy
2024-12-02 Bestätigt Robert W. Baird Outperform
2024-12-02 Bestätigt Stifel Buy
2024-09-03 Eingeleitet H.C. Wainwright Buy
2024-05-10 Eingeleitet Robert W. Baird Outperform
2024-02-05 Eingeleitet Piper Sandler Overweight
2024-01-23 Eingeleitet Stifel Buy
2023-11-21 Fortgesetzt Guggenheim Buy
2020-09-29 Eingeleitet Guggenheim Buy
2020-01-10 Eingeleitet Craig Hallum Buy
2019-12-23 Eingeleitet Oppenheimer Outperform
2018-02-13 Bestätigt Maxim Group Buy
Alle ansehen

Soleno Therapeutics Inc Aktie (SLNO) Neueste Nachrichten

pulisher
Apr 19, 2025

How To Trade (SLNO) - news.stocktradersdaily.com

Apr 19, 2025
pulisher
Apr 18, 2025

Soleno Therapeutics appoints CBIZ CPAs as new auditor By Investing.com - Investing.com Nigeria

Apr 18, 2025
pulisher
Apr 18, 2025

Soleno Therapeutics appoints CBIZ CPAs as new auditor - Investing.com Australia

Apr 18, 2025
pulisher
Apr 18, 2025

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Acquired by Geode Capital Management LLC - Defense World

Apr 18, 2025
pulisher
Apr 17, 2025

Franklin Resources Inc. Takes Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO) - Defense World

Apr 17, 2025
pulisher
Apr 14, 2025

Soleno launches Vykat XR (SLNO:NASDAQ) - Seeking Alpha

Apr 14, 2025
pulisher
Apr 14, 2025

Soleno Therapeutics launches FDA-approved PWS treatment By Investing.com - Investing.com South Africa

Apr 14, 2025
pulisher
Apr 14, 2025

Soleno Launches Pill For Hyperphagia In Prader-Willi Syndrome Patients But Retail’s Unmoved - MSN

Apr 14, 2025
pulisher
Apr 14, 2025

Soleno Therapeutics launches FDA-approved PWS treatment - Investing.com

Apr 14, 2025
pulisher
Apr 14, 2025

Soleno Therapeutics Announces VYKAT(TM) XR Launch - GlobeNewswire

Apr 14, 2025
pulisher
Apr 14, 2025

Breakthrough PWS Treatment VYKAT XR Now Available: First-Ever FDA Approval for Rare Disease - Stock Titan

Apr 14, 2025
pulisher
Apr 14, 2025

SLNO Stock Rallies on FDA Approval of Prader-Willi Syndrome Drug - MSN

Apr 14, 2025
pulisher
Apr 09, 2025

KLP Kapitalforvaltning AS Takes Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO) - Defense World

Apr 09, 2025
pulisher
Apr 08, 2025

Soleno Therapeutics (SLNO) Gains FDA Approval for Prader-Willi T - GuruFocus

Apr 08, 2025
pulisher
Apr 05, 2025

SLNO Quantitative Stock Analysis - Nasdaq

Apr 05, 2025
pulisher
Apr 03, 2025

Capnia Inc stock soars to 52-week high, hits $74 mark - Investing.com

Apr 03, 2025
pulisher
Apr 02, 2025

Soleno therapeutics SVP sells $265,156 in stock By Investing.com - Investing.com Australia

Apr 02, 2025
pulisher
Apr 02, 2025

Soleno therapeutics SVP sells $265,156 in stock - Investing.com

Apr 02, 2025
pulisher
Apr 01, 2025

Soleno Therapeutics, Inc. (NASDAQ:SLNO) CEO Bhatnagar Anish Sells 699,095 Shares - MarketBeat

Apr 01, 2025
pulisher
Apr 01, 2025

Piper Sandler maintains $93 target on Soleno stock post-VYKAT XR nod By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

Piper Sandler maintains $93 target on Soleno stock post-VYKAT XR nod - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

High Growth Tech Stocks To Watch In The US April 2025 - simplywall.st

Apr 01, 2025
pulisher
Apr 01, 2025

Soleno Therapeutics CEO sells $35.3 million in stock By Investing.com - Investing.com India

Apr 01, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics CEO sells $35.3 million in stock - Investing.com Australia

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics CEO Anish Bhatnagar sells $35.3m in stock - Investing.com Australia

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics CEO Anish Bhatnagar sells $35.3m in stock By Investing.com - Investing.com Nigeria

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics exec sells shares worth $9.5 million By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno therapeutics director Matthew Pauls sells $424,797 in stock By Investing.com - Investing.com Canada

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno therapeutics’ SVP Yen Kristen sells $4.88 million in stock - Investing.com India

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno therapeutics director Matthew Pauls sells $424,797 in stock - Investing.com Australia

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics exec sells $700,330 in stock - Investing.com India

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics CFO sells $4.88 million in stock - Investing.com Australia

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics Executives and Director Sell Shares - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics CCO sells shares worth $2.48m - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno therapeutics’ SVP Yen Kristen sells $4.88 million in stock By Investing.com - Investing.com UK

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics CCO sells shares worth $2.48m By Investing.com - Investing.com UK

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics CFO sells $4.88 million in stock By Investing.com - Investing.com UK

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics Executives Sell Shares - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics exec sells shares worth $9.5 million - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics’ SWOT analysis: FDA approval boosts rare disease stock - Investing.com Australia

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno stock price target raised to $100 at H.C. Wainwright By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno stock price target raised to $100 at H.C. Wainwright - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics’ SWOT analysis: FDA approval boosts rare disease stock By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 30, 2025

Soleno Therapeutics Stock (SLNO) Surges on FDA Green Light for PWS Treatment - Markets Insider

Mar 30, 2025
pulisher
Mar 29, 2025

Why Soleno Therapeutics Inc. (SLNO) Went Up Last Week? - Insider Monkey

Mar 29, 2025
pulisher
Mar 29, 2025

10 Stocks Outperform Broader Market Last Week - Insider Monkey

Mar 29, 2025

Finanzdaten der Soleno Therapeutics Inc-Aktie (SLNO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.07
price up icon 0.15%
$69.51
price down icon 4.32%
$32.19
price down icon 1.26%
$25.22
price up icon 2.48%
$101.81
price up icon 3.09%
biotechnology ONC
$229.22
price down icon 0.76%
Kapitalisierung:     |  Volumen (24h):